Deletion of nudB Causes Increased Susceptibility to Antifolates in Escherichia coli and Salmonella enterica

Antimicrob Agents Chemother. 2017 Apr 24;61(5):e02378-16. doi: 10.1128/AAC.02378-16. Print 2017 May.

Abstract

Co-trimoxazole, a fixed-dose combination of sulfamethoxazole (SMX) and trimethoprim (TMP), has been used for the treatment of bacterial infections since the 1960s. Since it has long been assumed that the synergistic effects between SMX and TMP are the consequence of targeting 2 different enzymes of bacterial folate biosynthesis, 2 genes (pabB and nudB) involved in the folate biosynthesis of Escherichia coli were deleted, and their effects on the susceptibility to antifolates were tested. The results showed that the deletion of nudB resulted in a lag of growth in minimal medium and increased susceptibility to both SMX and TMP. Moreover, deletion of nudB also greatly enhanced the bactericidal effect of TMP. To elucidate the mechanism of how the deletion of nudB affects the bacterial growth and susceptibility to antifolates, 7,8-dihydroneopterin and 7,8-dihydropteroate were supplemented into the growth medium. Although those metabolites could restore bacterial growth, they had no effect on susceptibilities to the antifolates. Reverse mutants of the nudB deletion strain were isolated to further study the mechanism of how the deletion of nudB affects susceptibility to antifolates. Targeted sequencing and subsequent genetic studies revealed that the disruption of the tetrahydromonapterin biosynthesis pathway could reverse the phenotype caused by the nudB deletion. Meanwhile, overexpression of folM could also lead to increased susceptibility to both SMX and TMP. These data suggested that the deletion of nudB resulted in the excess production of tetrahydromonapterin, which then caused the increased susceptibility to antifolates. In addition, we found that the deletion of nudB also resulted in increased susceptibility to both SMX and TMP in Salmonella enterica Since dihydroneopterin triphosphate hydrolase is an important component of bacterial folate biosynthesis and the tetrahydromonapterin biosynthesis pathway also exists in a variety of bacteria, it will be interesting to design new compounds targeting dihydroneopterin triphosphate hydrolase, which may inhibit bacterial growth and simultaneously potentiate the antimicrobial activities of antifolates targeting other components of folate biosynthesis.

Keywords: nudB; sulfamethoxazole; susceptibility; tetrahydromonapterin; trimethoprim.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Escherichia coli / drug effects*
  • Escherichia coli / genetics
  • Escherichia coli / growth & development
  • Escherichia coli Proteins / genetics*
  • Escherichia coli Proteins / metabolism
  • Folic Acid Antagonists / pharmacology*
  • Gene Deletion
  • Microbial Sensitivity Tests
  • Neopterin / analogs & derivatives
  • Neopterin / pharmacology
  • Pterins / pharmacology
  • Pyrophosphatases / antagonists & inhibitors
  • Pyrophosphatases / genetics*
  • Salmonella enterica / drug effects*
  • Salmonella enterica / genetics
  • Salmonella enterica / growth & development
  • Tetrahydrofolate Dehydrogenase / metabolism
  • Trimethoprim, Sulfamethoxazole Drug Combination / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Escherichia coli Proteins
  • Folic Acid Antagonists
  • Pterins
  • 7,8-dihydroneopterin
  • dihydropteroate
  • Neopterin
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • FolM protein, E coli
  • Tetrahydrofolate Dehydrogenase
  • NudB protein, E coli
  • Pyrophosphatases
  • dihydroneopterin triphosphate pyrophosphohydrolase